AH 23848 (calcium salt) is a selective thromboxane A2 receptor antagonist used primarily in research settings to study its effects on TP receptors, which are involved in platelet aggregation, vascular smooth muscle contraction, and inflammation. It has been utilized in experimental studies to understand its role in modulating cardiovascular functions, such as vasoconstriction and thrombosis prevention. Additionally, its interactions have been explored in reproductive health research, including effects on uterine activity relevant to conditions like preterm labor. This compound serves as a valuable tool in pharmacological studies aimed at developing targeted therapies for disorders involving thromboxane pathways, including cardiovascular and inflammatory diseases.